These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7657409)

  • 1. Present status of vaccination against HIV-1 infection.
    Girard M
    Int J Immunopharmacol; 1995 Feb; 17(2):75-8. PubMed ID: 7657409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model of vaccination against HIV to prevent the development of AIDS.
    Nowak MA; McLean AR
    Proc Biol Sci; 1991 Nov; 246(1316):141-6. PubMed ID: 1685238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response to HIV: implications for vaccine development.
    Bolognesi DP
    Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
    Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
    Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
    Wolfs TF; Nara PL; Goudsmit J
    Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees.
    Bagarazzi ML; Boyer JD; Javadian MA; Chattergoon M; Dang K; Kim G; Shah J; Wang B; Weiner DB
    J Med Primatol; 1997; 26(1-2):27-33. PubMed ID: 9271186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.
    Sarin PS; Mora CA; Naylor PH; Markham R; Schwartz D; Kahn J; Heseltine P; Gazzard B; Youle M; Rios A
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):401-7. PubMed ID: 7580834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK
    J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental vaccination against HIV-1 protects the chimpanzee against challenge with injections of infected lymphocytes].
    Girard M; Kieny MP; Barré-Sinoussi F; Nara P; Muchmore E; Fultz P
    Bull Acad Natl Med; 1992 Jun; 176(6):921-34; discussion 935. PubMed ID: 1464038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
    Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
    AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.
    Bruck C; Thiriart C; Fabry L; Francotte M; Pala P; Van Opstal O; Culp J; Rosenberg M; De Wilde M; Heidt P; Heeney J
    Vaccine; 1994 Sep; 12(12):1141-8. PubMed ID: 7998425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?
    Koff WC; Schultz AM
    J Clin Immunol; 1996 May; 16(3):127-33. PubMed ID: 8734355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a vaccine for the prevention of AIDS, a critical appraisal.
    Karzon DT; Bolognesi DP; Koff WC
    Vaccine; 1992; 10(14):1039-52. PubMed ID: 1281948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
    Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
    Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS vaccines: concepts and first trials.
    Sonigo P; Montagnier L; Tiollais P; Girard M
    Immunodefic Rev; 1989; 1(4):349-66. PubMed ID: 2698645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.